BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2179858)

  • 1. Commentary: results of efficacy trials in Alaska and Finland of Haemophilus influenzae type b conjugate vaccine.
    Ward J
    Pediatrics; 1990 Apr; 85(4 Pt 2):667. PubMed ID: 2179858
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatrics academy issues recommendations on use of Haemophilus influenzae type b conjugate vaccine.
    Clin Pharm; 1988 Sep; 7(9):634. PubMed ID: 3266482
    [No Abstract]   [Full Text] [Related]  

  • 3. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccine.
    Pediatrics; 1988 Jun; 81(6):908-11. PubMed ID: 3259309
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in vaccinated children who developed Haemophilus disease.
    Weinberg GA; Murphy TV; Granoff DM
    Pediatrics; 1990 Oct; 86(4):617-20. PubMed ID: 2216629
    [No Abstract]   [Full Text] [Related]  

  • 6. Conjugated Haemophilus influenzae type b vaccine.
    Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis.
    Wenger JD; Ward JI; Broome CV
    Curr Clin Top Infect Dis; 1989; 10():306-39. PubMed ID: 2679698
    [No Abstract]   [Full Text] [Related]  

  • 8. Finnish efficacy trials with Haemophilus influenzae type b vaccines.
    Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(15):296-8. PubMed ID: 8479415
    [No Abstract]   [Full Text] [Related]  

  • 10. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group.
    Ward J; Brenneman G; Letson GW; Heyward WL
    N Engl J Med; 1990 Nov; 323(20):1393-401. PubMed ID: 2233906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance of epiglottitis during large-scale vaccination with Haemophilus influenzae type B conjugate vaccine among children in Finland.
    Takala AK; Peltola H; Eskola J
    Laryngoscope; 1994 Jun; 104(6 Pt 1):731-5. PubMed ID: 8196448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines.
    Pediatrics; 1993 Sep; 92(3):480-8. PubMed ID: 8361814
    [No Abstract]   [Full Text] [Related]  

  • 13. Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease.
    Weinberg GA; Granoff DM
    J Pediatr; 1988 Oct; 113(4):621-31. PubMed ID: 3050001
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-marketing surveillance of adverse events following ProHIBit vaccine--British Columbia.
    Meekison W; Hutcheon M; Guasparini R; Arnott M; Scheifele D; Grace M; Humphreys G; Barreto L
    Can Dis Wkly Rep; 1989 Jul; 15(28):143-5. PubMed ID: 2791073
    [No Abstract]   [Full Text] [Related]  

  • 15. The 1990s: a decade of new vaccines.
    Murphy TV
    Pediatr Infect Dis J; 1991 Feb; 10(2):89-91. PubMed ID: 2062619
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemophilus influenzae type b vaccines: lessons for the future.
    Ward JI; Broome CV; Harrison LH; Shinefield H; Black S
    Pediatrics; 1988 Jun; 81(6):886-93. PubMed ID: 3259307
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children.
    Käyhty H; Peltola H; Eskola J
    Pediatr Infect Dis J; 1988 Aug; 7(8):574-7. PubMed ID: 3050853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Jan; 37(2):13-6. PubMed ID: 3122004
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
    Madore DV; Johnson CL; Phipps DC; Myers MG; Eby R; Smith DH
    Pediatrics; 1990 Oct; 86(4):527-34. PubMed ID: 2216616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus influenzae type b vaccine.
    Anderson P; Pichichero ME
    Pediatrics; 1989 Jan; 83(1):145-6. PubMed ID: 2909967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.